NFKB1 and head and neck squamous cell carcinoma: Taken together, these data strongly suggest that EKB-569 may exert radiosensitization at least in part by selectively targeting IR-induced NFκB dependent survival signaling, that potentiate radiotherapy in effective HNSCC cell killing.